
|Articles|October 15, 2012
Screening for those at high risk for T2DM does not reduce mortality within 10 years, study finds
Screening patients who are at high risk for diabetes does not reduce their all-cause, cardiovascular, or diabetes-related mortality within 10 years, according to a study published Oct. 4 in The Lancet
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
3
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
4
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
5







































